Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 2,350,000 7.290% | 1,100,000![]() (+88.00%) | Filing History |
2025-02-07 1:21 pm Purchase | 2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Invesco Ltd. IVZ | 1,775,760 5.500% | 1,775,760![]() (New Position) | Filing History |
2024-11-13 5:13 pm Purchase | 2024-09-30 | 13G | Collegium Pharmaceutical, Inc. COLL | PRINCIPAL GLOBAL INVESTORS | 1,745,663 5.420% | 1,745,663![]() (New Position) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 1,250,000 3.880% | -1,508,253![]() (-54.68%) | Filing History |
2024-11-13 2:39 pm Purchase | 2024-08-02 | 13G | Collegium Pharmaceutical, Inc. COLL | RENAISSANCE TECHNOLOGIES LLC | 1,656,069 5.140% | 1,656,069![]() (New Position) | Filing History |
2024-02-14 12:04 pm Purchase | 2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Eventide Asset Management, LLC | 2,630,478 8.070% | 885![]() (+0.03%) | Filing History |
2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | Collegium Pharmaceutical, Inc. COLL | The Vanguard Group | 2,312,786 7.090% | 104,675![]() (+4.74%) | Filing History |
2024-02-12 06:06 am Sale | 2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 2,758,253 8.460% | -575,375![]() (-17.26%) | Filing History |
2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | BlackRock Inc. BLK | 5,786,527 17.700% | 55,222![]() (+0.96%) | Filing History |
2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 3,333,628 9.930% | 727,128![]() (+27.90%) | Filing History |
2023-02-09 11:16 am Sale | 2022-12-30 | 13G | Collegium Pharmaceutical, Inc. COLL | The Vanguard Group | 2,208,111 6.580% | -79,306![]() (-3.47%) | Filing History |
2023-02-09 10:36 am Sale | 2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | JANUS HENDERSON GROUP PLC JHG | 1,481,170 4.400% | -506,325![]() (-25.48%) | Filing History |
2023-01-30 09:55 am Purchase | 2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | BlackRock Inc. BLK | 5,731,305 17.100% | 99,645![]() (+1.77%) | Filing History |
2022-09-12 08:25 am Sale | 2022-08-31 | 13G | Collegium Pharmaceutical, Inc. COLL | JANUS HENDERSON GROUP PLC JHG | 1,987,495 5.800% | -1,786,808![]() (-47.34%) | Filing History |
2022-02-14 9:01 pm Sale | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Perceptive Advisors LLC | 0 0.000% | -2,058,068![]() (Position Closed) | Filing History |
2022-02-14 12:04 pm Purchase | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Eventide Asset Management, LLC | 2,629,593 7.600% | 201,617![]() (+8.30%) | Filing History |
2022-02-14 09:40 am Sale | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Camber Capital Management LP | 1,050,000 3.040% | -950,000![]() (-47.50%) | Filing History |
2022-02-14 08:41 am Purchase | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 2,606,500 7.540% | 680,217![]() (+35.31%) | Filing History |
2022-02-10 3:21 pm Sale | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | JANUS HENDERSON GROUP PLC JHG | 3,774,303 10.900% | -1,313,206![]() (-25.81%) | Filing History |
2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | The Vanguard Group | 2,287,417 6.620% | 556,565![]() (+32.16%) | Filing History |